Biotech News Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech News

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gary Mohilner who wrote (6300)	8/13/2008 11:40:16 PM
From: Biotech Jim	Read Replies (1) of 7143

<We have Pharma's who say new drugs cost billions to bring to market and have their data go unchallenged though small biotech's with less than $100 million in the bank consistently bring drugs through trials.> I think there is a bit ( a lot) of hyperbole here. First, it costs big pharma "billions", and that small biotechs that have <$100M provides no statement on what it costs? Don't you think that the trials are indication dependent and issue dependent based on the molecule and mechanism? I think the bigger issues regarding costs is that often it encompasses "dry holes" and that the genomic revolution does not guarantee efficacy in the absence of mechanistic side effects. Most companies do not sufficiently deal up front with the payor issue as well. It is hyperbole like you provide that confuse the issues and detract from well thought out discussions etc. I suspect you are unaware of doctors "learning how to use certain drugs as well, and what it takes clinically to understand this. JMHO. But everyone is entitled to their opinion. BJ

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next